Thiazoles
Apexbio Technology LLC ANTI-C-MET TELISOTUZUMAB-50mg
Anti-HGFR/c-Met Antibody (Telisotuzumab) (CAS No 1781223-80-0) is a monoclonal antibody used in cancer research specifically targeting the hepatocyte growth factor receptor (c-Met) pathway This antibody is designed to inhibit the binding of HGF to c-Met disrupting downstream signaling pathways involved in tumor proliferation survival and metastasis It exhibits strong in vitro activity in the nanomolar to low micromolar range indicating potent inhibition of cancer cell growth Telisotuzumab is commonly utilized in various cell models including cancer cell lines and animal studies to assess its therapeutic potential and efficacy It is also employed in drug screening to identify potential combinations or new therapeutic strategies Experimental concentrations typically depend on the specific research design ensuring tailored applicability to diverse experimental frameworks and objectives
Aobchem (6-Methoxynaphthalen-2-yl)trimethylsilane | ≥95% | CAS 18410-39-4 | C14H18OSi | 1g
(6-Methoxynaphthalen-2-yl)trimethylsilane | ≥95% | CAS 18410-39-4 | C14H18OSi | 1g
Aobchem 5-(3-Isopropylphenyl)thiazol-2-amine | ≥97% | CAS 2012823-15-1 | C12H14N2S | 500mg
5-(3-Isopropylphenyl)thiazol-2-amine | ≥97% | CAS 2012823-15-1 | C12H14N2S | 500mg
Aobchem 4-Butyl- -methylbenzenemethanol | ≥95% | CAS 125639-56-7 | C12H18O | 500mg
4-Butyl- -methylbenzenemethanol | ≥95% | CAS 125639-56-7 | C12H18O | 500mg
Aobchem 1-(5-Benzylpyridin-3-yl)ethanone | 95% | C14H13NO | 500mg
1-(5-Benzylpyridin-3-yl)ethanone | 95% | C14H13NO | 500mg
Aobchem 2-(6-Isopropoxypyridin-3-yl)propan-2-ol | 95% | CAS 2969378-90-1 | C11H17NO2 | 500mg
2-(6-Isopropoxypyridin-3-yl)propan-2-ol | 95% | CAS 2969378-90-1 | C11H17NO2 | 500mg
![eMolecules 2415163-55-0 | [2-(tert-Butoxycarbonylamino)-7-fluoro-1,3-benzothiazol-4-yl]boronic acid | Combi-Blocks, Inc.312.120 | C12H14BFN2O4S | 98.000 | CC(C)(C)OC(=O)Nc1nc2c(ccc(F)c2s1)B(O)O | 1g | 686216158](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000164726.jpg-250.jpg)
eMolecules 2415163-55-0 | [2-(tert-Butoxycarbonylamino)-7-fluoro-1,3-benzothiazol-4-yl]boronic acid | Combi-Blocks, Inc.312.120 | C12H14BFN2O4S | 98.000 | CC(C)(C)OC(=O)Nc1nc2c(ccc(F)c2s1)B(O)O | 1g | 686216158
[2-(tert-Butoxycarbonylamino)-7-fluoro-1,3-benzothiazol-4-yl]boronic acid | Combi-Blocks, Inc. | 2415163-55-0312.120 | C12H14BFN2O4S | 98.000 | CC(C)(C)OC(=O)Nc1nc2c(ccc(F)c2s1)B(O)O | 1g | 686216158
eMolecules 1858257-27-8 | Ethyl 2-(3-Methyl-2-pyridyl)-4-methylthiazole-5-carboxylate | Oakwood Chemical | MFCD16660852 | 262.330 | C13H14N2O2S | 97.000 | CCOC(=O)c1sc(nc1C)-c1ncccc1C | 1g | 537705758
Ethyl 2-(3-Methyl-2-pyridyl)-4-methylthiazole-5-carboxylate | Oakwood Chemical | 1858257-27-8 | MFCD16660852 | 262.330 | C13H14N2O2S | 97.000 | CCOC(=O)c1sc(nc1C)-c1ncccc1C | 1g | 537705758
Medchemexpress LLC Chalcogen-containing ionizable cationic lipidoid | 2227214-78-8 | 98.1% | 750.15 g/mol | C44H83N3O6 | 5 MG
93-O17O is a chalcogen-containing ionizable cationic lipidoid (C44H83N3O6, MW 750.15 g/mol) used to formulate lipid nanoparticles (LNPs) for nucleic acid delivery research. Supplied as a research-grade, high-purity lipid for formulation, transfection, and preclinical studies. Handle and store according to safety guidance.
- Used for LNP formulation and mRNA/nucleic acid delivery studies.
- Chalcogen-containing ionizable cationic structure to facilitate endosomal release.
- High purity suitable for formulation work (≈98.1%).
- Available in small-quantity packages for research use.
- Storage: pure material stable at -20°C; in solvent recommended -80°C for extended storage.
Aobchem (4-Fluoro-3-methyl-5-(methylthio)phenyl)(phenyl)methanol | 95% | C15H15FOS | 1g
(4-Fluoro-3-methyl-5-(methylthio)phenyl)(phenyl)methanol | 95% | C15H15FOS | 1g
Aobchem 3-Fluoro-2-methoxy-4-(methylthio)benzoic acid | 97% | CAS 2807466-01-7 | C9H9FO3S | 500mg
3-Fluoro-2-methoxy-4-(methylthio)benzoic acid | 97% | CAS 2807466-01-7 | C9H9FO3S | 500mg
Aobchem (2-Chloro-6-fluoro-3-(methylthio)phenyl)boronic acid | 97% | C7H7BClFO2S | 250mg
(2-Chloro-6-fluoro-3-(methylthio)phenyl)boronic acid | 97% | C7H7BClFO2S | 250mg
Medchemexpress LLC Pyrazoline-based chloroacetamide | 99.6% | 404.89 g·mol⁻¹ | C24H21ClN2O2 | 10 MG
MM-02-57 is a covalent small-molecule recruiter that targets the DDB1 adaptor to engage the CUL4A ubiquitin ligase complex for targeted protein degradation studies. It is provided as a solid powder intended for laboratory research use only.
- Covalent recruiter of DDB1 for CUL4A adaptor engagement.
- Designed for use in targeted protein degradation and chemoproteomics research.
- Pyrazoline-based chloroacetamide scaffold with cysteine-reactive electrophile.
- Molecular weight 404.89 g·mol⁻¹; chemical formula C24H21ClN2O2.
- Supplied as a solid powder with cold storage recommendations for stability.
- High reported purity from distributor analyses, suitable for biochemical assays.